Tandem Diabetes Care (TNDM) Other Accumulated Expenses (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Other Accumulated Expenses data on file, last reported at $84.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 8.4% year-over-year to $84.1 million; the trailing twelve-month figure through Mar 2026 stood at $84.1 million (down 8.4% YoY), and the FY2025 full-year result was $75.2 million, up 52.57% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $84.1 million, up from $75.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $100.0 million in Q2 2025 and bottomed at $22.9 million in Q1 2022.
• The 5-year median for Other Accumulated Expenses is $33.9 million (2023), against an average of $48.7 million.
• The widest annual swing landed in 2025, when Other Accumulated Expenses jumped 202.63%; it then declined 8.4% in 2026.
• A 5-year view of Other Accumulated Expenses shows it stood at $29.3 million in 2022, then dropped by 2.94% to $28.5 million in 2023, then soared by 73.26% to $49.3 million in 2024, then soared by 52.57% to $75.2 million in 2025, then gained by 11.78% to $84.1 million in 2026.
• The last three Other Accumulated Expenses figures came in at $84.1 million (Q1 2026), $75.2 million (Q4 2025), and $96.9 million (Q3 2025), per Business Quant data.

Peer Comparison